510(k) Report

510(k) · Cleared

Cleared

Diazyme Apolipoprotein a-1 Assay

K072977510(k) TraditionalCleared Jul 16, 2008268-day reviewClass I21 CFR 862.1475

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

General Atomics · MSJ Apolipoproteins

Cleared on Jul 16, 2008 as substantially equivalent to K993345 (Kamiya Biomedical Co., 1999) after a 268-day review. Its family tree reaches back 1 generation to 1999.

Decided
Jul 16, 2008
Review
268 days
Class
Class I
Product code
MSJ
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K993345 (1999). No later device cites it as a predicate yet.

K993345 · K-Assay Apo AI · Kamiya Biomedical Co. · 19991995200020052010
K993345 · K-Assay Apo AI · Kamiya Biomedical Co. · 19990
  1. Root · 1 generation backK993345 K-Assay Apo AIKamiya Biomedical Co. · 1999
  2. This deviceK072977 Diazyme Apolipoprotein a-1 AssayGeneral Atomics · 2008
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K993345K-Assay Apo AIKamiya Biomedical Co.1999—
0 (this device)K072977Diazyme Apolipoprotein a-1 AssayGeneral Atomics2008—
FIG. 1 — Lineage of K072977, 1999–2008Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MSJ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K993345K-Assay Apo AI
Summary page 1
…Lipoprotein test system, we are claiming equivalence [807.92(a) (3) to K-ASSAY APO Al ASSAY (k993345) manufactured by Kamiya Biomedical Company…
Kamiya Biomedical Co.1999—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.

How does its category compare?

All MSJ devices

MSJ Apolipoproteins: FDA decisions, review times, recalls and adverse event reports over 20 years. 2008, this device’s year, is highlighted.

FDA decisions per year · MSJ

2in 2008

2007: 22008: 2
2007high 2 (2007) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MSJ

Too few MSJ 510(k)s in any year since 2007 to give a median.

Recalls per year · MSJ

No recall names MSJ since 2007.

Adverse event reports per year · MSJ

No MAUDE report names MSJ since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
20082—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20230—00
20240—00
20250—00
20260—0—

What is it indicated for?

The Diazyme Apolipoprotein A-I Assay is intended for the in vitro quantitative determination of apolipoprotein A-I (apo A-I) in serum. It can be used as an aid for assessing the risk of coronary artery disease. For in vitro Diagnostic use.

For calibration of the Diazyme Apolipoprotein A-I Assay in serum. For in vitro Diagnostic Use.

To monitor the performance of Diazyme Apolipoprotein A-I Assay in serum. For in vitro Diagnostic Use.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K072977: Diazyme Apolipoprotein a-1 Assay.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K072977

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026